Brevan Howard Capital Management’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-54,034
Closed -$155K 2222
2025
Q4
$155K Buy
54,034
+3,875
+8% +$10.7K ﹤0.01% 1630
2025
Q3
$204K Sell
50,159
-61,965
-55% -$247K ﹤0.01% 1748
2025
Q2
$437K Buy
112,124
+96,869
+635% +$305K ﹤0.01% 1411
2025
Q1
$44.1K Buy
+15,255
New +$61.9K ﹤0.01% 1095
2024
Q4
Sell
-12,373
Closed -$55.3K 1129
2024
Q3
$55.3K Buy
+12,373
New +$58.1K ﹤0.01% 1092

Other funds holding DH

Brevan Howard Capital Management's DH Position: Q1 2026 in Review

Brevan Howard Capital Management sold out of Definitive Healthcare (DH) in Q1 2026, closing a stake of 54,034 shares — an estimated $155K sold.

Brevan Howard Capital Management first reported a position in DH in Q3 2024 and held it in 5 quarters. The position peaked at $437K in Q2 2025. 119 funds tracked by Wall St. Rank hold DH as of Q1 2026.

  • Brevan Howard Capital Management reported no remaining Definitive Healthcare position as of Q1 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 54,034 Definitive Healthcare shares in Q1 2026, an estimated $155K.
  • Brevan Howard Capital Management first reported a position in Definitive Healthcare in Q3 2024 and held it in 5 quarters.
  • Brevan Howard Capital Management's Definitive Healthcare position peaked at $437K in Q2 2025.
  • 119 funds tracked by Wall St. Rank held Definitive Healthcare as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.